Ryan T. Muir

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy et al. · The Lancet · 2024 · 101 citations · Full text

Thrombosis, Superiority Trial, Ischemic Stroke +12

Trail Making Test Elucidates Neural Substrates of Specific Poststroke Executive Dysfunctions

Ryan T. Muir, Benjamin Lam, Kie Honjo et al. · Stroke · 2015 · 76 citations · Full text

Periodic Limb Movements and White Matter Hyperintensities in First-Ever Minor Stroke or High-Risk Transient Ischemic Attack

Mark I. Boulos, Brian J. Murray, Ryan T. Muir et al. · SLEEP · 2016 · 56 citations · Full text

Validity of Self-Report of Cardiovascular Risk Factors in a Population at High Risk for Stroke

Ayan Dey, Akram Alyass, Ryan T. Muir et al. · Journal of Stroke and Cerebrovascular Diseases · 2015 · 41 citations

Cardiovascular Epidemiology, Cardiovascular Disease, Medicine +10

Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome

Ioanna Deni, Barbara H. Stokes, Kurt E. Ward et al. · Cell chemical biology · 2023 · 20 citations · Full text

Drug Target, Antiparasitic Agent, Malaria +18